Four-year data from ILLUMENATE trial reaffirm safety profile of Stellarex - Vascular News

Four-year data from ILLUMENATE trial reaffirm safety profile of Stellarex  Vascular News

Comments

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management